Thomas Hope, MD

Articles by Thomas Hope, MD

Examining Developments in Safe Administration of Nuclear Agents

November 26th 2025

Thomas Hope, MD, believes that an NRC initiative to update infiltration guidelines may organically address concerns that H.R. 2541 outlines.

Thomas Hope, MD, had not observed an adverse effect attributable to an infiltration across more than a decade of administering nuclear agents at UCSF.

Does Increased Infiltration Reporting Correlate with Better Outcomes?

ByThomas Hope, MD

November 25th 2025

Thomas Hope, MD, had not observed an adverse effect attributable to an infiltration across more than a decade of administering nuclear agents at UCSF.

Thomas Hope, MD

Articles by Thomas Hope, MD

Examining Developments in Safe Administration of Nuclear Agents

Does Increased Infiltration Reporting Correlate with Better Outcomes?

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

FDA Accepts sNDA for Taletrectinib in ROS1-Positive NSCLC